Effects of Fermented Rye Bran Products on Helicobacter Pylori (HP) Infection and Metabolic Risk Factors (RyeClaim)
Effects of Fermented Rye Bran Products on HP Infection and Metabolic Risk Factors
Sponsor: Fudan University
This NA trial investigates H. Pylori Infections and Non-communicable Diseases and is currently ongoing. Fudan University leads this study, which shows 11 recorded versions since 2015 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
11 versions recorded-
Jul 2025 — Present [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Jul 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jul 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Oct 2021 — Jul 2023 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Mar 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting NA
-
Apr 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Dec 2018 — Apr 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fudan University
- Shanghai Zhongye Hospital
- Swedish University of Agricultural Sciences
For direct contact, visit the study record on ClinicalTrials.gov .